Key Insights

Highlights

Success Rate

82% trial completion

Published Results

23 trials with published results (18%)

Research Maturity

59 completed trials (47% of total)

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 72/100

Termination Rate

10.4%

13 terminated out of 125 trials

Success Rate

81.9%

-4.6% vs benchmark

Late-Stage Pipeline

5%

6 trials in Phase 3/4

Results Transparency

39%

23 of 59 completed with results

Key Signals

23 with results82% success13 terminated

Data Visualizations

Phase Distribution

93Total
Not Applicable (40)
Early P 1 (1)
P 1 (17)
P 2 (29)
P 3 (1)
P 4 (5)

Trial Status

Completed59
Recruiting22
Unknown14
Terminated13
Active Not Recruiting6
Withdrawn5

Trial Success Rate

81.9%

Benchmark: 86.6%

Based on 59 completed trials

Clinical Trials (125)

Showing 20 of 20 trials
NCT03762733Enrolling By Invitation

Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies

NCT05579366Phase 1Recruiting

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

NCT07106359Not ApplicableRecruiting

Initial Testing of a Behavioral Intervention About Genetic Services for Families at Risk of Lynch Syndrome

NCT06904365Active Not RecruitingPrimary

Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women

NCT04038619Phase 1Recruiting

Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients

NCT07668284Phase 1Not Yet Recruiting

COQ10 and Vitamin E for Off-Target Radiation Toxicity

NCT03476681Phase 1Active Not Recruiting

Study of NEO-201 in Solid Tumors Expansion Cohorts

NCT06527157RecruitingPrimary

Investigations of Reproductive Cancers in Women

NCT05708950Phase 1Completed

A Clinical Trial of KVA12123 [TBS-2025] Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)

NCT05758688Phase 2Recruiting

PROton Therapy for Post Surgical Treatment of GYNecologic Cancer

NCT05916196Phase 2RecruitingPrimary

[18F]FES PET/.CT in Uterine Cancer

NCT06024109Recruiting

Performance of SYMMCORA® vs. V-Loc® Suture Material in Patients Undergoing Laparoscopic Total Hysterectomy

NCT05743517Not ApplicableRecruiting

Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)

NCT07581288Not Yet Recruiting

Measurement of Urinary Hormones in Patients With Abnormal Uterine Bleeding to Study Uterine Cancer Progression

NCT07542704Phase 1Not Yet Recruiting

A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies

NCT05559879Phase 1Recruiting

Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma

NCT06447064Recruiting

Cancer Loyalty Card Study 2 (CLOCS-2)

NCT05990426Not ApplicableRecruiting

Alternate Day Fasting After Surgery for Patients Undergoing Chemotherapy

NCT06662435Not ApplicableCompleted

GYNecologic Cancer-Related COGnitive Impairment

NCT05977621RecruitingPrimary

Trans-Rectal Ultrasound of the Female Pelvis for Real-Time MRI-US Fusion Based Needle Tracking

Scroll to load more

Research Network

Activity Timeline